ClinicalKey AI Wins “AI Innovation Award” in 8th Annual MedTech Breakthrough Awards Program

Elsevier, a global leader in scientific information and data analytics, has been selected as winner of the “AI Innovation Award” in the 8^th annual MedTech Breakthrough Awards program. MedTech Breakthrough 새 탭/창에서 열기, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, presented Elsevier with the award for the breakthrough innovation of Elsevier’s ClinicalKey AI.

Elsevier partnered with OpenEvidence to develop ClinicalKey AI, expanding ClinicalKey’s capabilities with the latest AI advancements. ClinicalKey AI combines trusted, evidence-based clinical content with conversational search powered by generative AI to support clinicians in delivering high-quality patient care.

ClinicalKey AI generates responses based on information from validated sources, including Elsevier’s proprietary point of care content, medical reference texts, Elsevier and trusted third-party journal abstracts, and government publications. By evaluating these evidence-based content sources that are updated daily, ClinicalKey AI can summarize a tailored response to clinical queries. Responses also include references with linked citations to supporting published evidence.

“As a company dedicated to empowering clinicians and improving outcomes, we are committed to ensuring clinicians have access to reliable, evidence-based medical information. ClinicalKey AI is designed for clinical practice, and enables faster and more precise answers to a wide variety of clinical questions based on the latest scientific research,” said Jan Herzhoff, President of Health Markets at Elsevier. “This is critical given the overwhelming volume of complex cases that clinicians are required to manage every day. ClinicalKey AI sets a new standard for medical decision-making support, and we are delighted to be recognized by MedTech Breakthrough with the AI Innovation Award.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“ClinicalKey AI makes it possible for clinicians to easily extract precise knowledge from the vast body of clinical information, ensure decisions are based on the latest evidence, and help hospital leaders provide the right AI technology for supporting clinical decision making,” said Steve Johansson, managing director, MedTech Breakthrough. “We’re proud to award Elsevier’s solution with AI Innovation for this year’s MedTech Breakthrough Award.”

By building upon AI technology designed for healthcare and tested by over 30,000 clinicians, Elsevier continues their commitment to responsible AI. They continuously evaluate the accuracy of ClinicalKey AI’s output with their team of over 100 clinicians and their two health system development partners. Debuting with live demonstrations at HIMSS this year, ClinicalKey AI shows the power of AI innovation in healthcare, backed by AI safeguards and trusted evidence-based content.

ClinicalKey AI allows clinicians to ask questions the way they would speak to a trusted specialist and receive answers quickly. The solution’s intuitive clinical reasoning assistant is designed so clinicians can quickly search a comprehensive base of clinical knowledge. Clinicians can access this information at the point of care, while also accounting for patient context—including multiple comorbidities and current medications. All of this can be personalized to the individual user within their profile settings.

ClinicalKey AI allows clinicians to explore a variety of disease conditions and treatment options. Hospital leaders are then able to build a sustainable culture around evidence-based practice, which can help manage costs and enhance patient care.

####

About MedTech Breakthrough

Part of Tech Breakthrough 새 탭/창에서 열기, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com 새 탭/창에서 열기.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야를 선도하는 글로벌 기업입니다. 100년 넘게 과학과 의료의 발전을 뒷받침하며 인류의 더 나은 미래를 위해 노력해왔습니다. 우리는 전 세계 170개국의 대학 및 기업 연구자, 의사, 간호사, 차세대 보건의료 인력과 교육자들이 중요한 업무를 수행할 수 있도록 지원하고 있습니다. 우리는 신뢰할 수 있는 근거 기반의 과학과 의학 콘텐츠에 첨단 인공지능(AI) 기술을 접목한 핵심 인사이트와 혁신적인 솔루션을 제공함으로써, 이들의 더 나은 성과 달성을 돕고자 합니다. 우리는 제품과 조직 문화 전반에 포용성과 지속 가능성의 가치를 반영하고, 함께하는 커뮤니티와의 협력을 통해 이를 실천해 나가고 있습니다. 엘스비어 재단(Elsevier Foundation 새 탭/창에서 열기)은 세계 곳곳에서 연구 및 보건 분야의 협력 사업을 후원하고 있습니다.

엘스비어는 전문가 및 비즈니스 고객을 위한 정보 기반 분석 및 의사결정 도구를 제공하는 글로벌 기업 RELX 새 탭/창에서 열기의 계열사입니다. 자세한 내용은 www.elsevier.com에서 확인하실 수 있으며, SNS @ElsevierConnect를 통해 최신 소식도 실시간으로 받아보실 수 있습니다.